Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 277, 119458
Abstract
No abstract availableKeywords
Funding Information
- Sichuan University (2019HXFH038, 2021JDRC0045, 2021JDRC0169, 2021YFS0164)
- West China Hospital, Sichuan University (2019HXFH038, 2021JDRC0045, 2021JDRC0169, 2021YFS0164)
- Sichuan Provincial Science and Technology Support Program (2019HXFH038, 2021JDRC0045, 2021JDRC0169, 2021YFS0164)
This publication has 93 references indexed in Scilit:
- Mesenchymal Stem Cell Conditioning Promotes Rat Oligodendroglial Cell MaturationPLOS ONE, 2013
- Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cellsStem Cell Research & Therapy, 2013
- Extracellular vesicles: Exosomes, microvesicles, and friendsJournal of Cell Biology, 2013
- Updated assessment of the prevalence, spectrum and case definition of autoimmune diseaseAutoimmunity Reviews, 2012
- Dysregulation of immune homeostasis in autoimmune diseasesNature Medicine, 2012
- Exosomes: Extracellular organelles important in intercellular communicationJournal of Proteomics, 2010
- Mesenchymal stem cell secretes microparticles enriched in pre-microRNAsNucleic Acids Research, 2009
- MicroRNAs: new regulators of immune cell development and functionNature Immunology, 2008
- Mesenchymal stem cells inhibit natural killer–cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2Blood, 2008
- The functions of animal microRNAsNature, 2004